Citation Impact
Citing Papers
HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol
2005 Standout
Trained immunity: A program of innate immune memory in health and disease
2016 StandoutScience
Prevalence of the Metabolic Syndrome in Individuals with Hyperuricemia
2007
Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment – a prospective, controlled study
2006
IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial
2008
Epidemiology, risk factors, and lifestyle modifications for gout.
2006
Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score
2005
Inflammation and Its Relationship to Insulin Resistance, Type 2 Diabetes Mellitus, and Endothelial Dysfunction
2003
Gout: On the brink of novel therapeutic options for an ancient disease
2004
Cardiovascular disease in rheumatoid arthritis: state of the art and future perspectives
2010
Atherosclerotic Vascular Disease in the Autoimmune Rheumatologic Patient
2015
Methods of investigation for cardiac autonomic dysfunction in human research studies
2011
Serum uric acid and cardiovascular disease: Recent developments, and where do they leave us?
2005
Gout and hyperuricemia
2002
Inflammation and metabolic disorders
2006 StandoutNature
Hypothesis: fructose-induced hyperuricemia as a causal mechanism for the epidemic of the metabolic syndrome
2005
Rheumatoid arthritis
2016 Standout
Obesity, Weight Change, Hypertension, Diuretic Use, and Risk of Gout in Men
2005
Weight loss for overweight and obese individuals with gout: a systematic review of longitudinal studies
2017
Chronic inflammation in the etiology of disease across the life span
2019 Standout
The Risk of Metabolic Syndrome in Patients with Rheumatoid Arthritis: A Meta-Analysis of Observational Studies
2013
Recent advances in the management of gout and hyperuricemia
2005
EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis
2009 Standout
Gout: can management be improved?
2001
Effects of skim milk powder enriched with glycomacropeptide and G600 milk fat extract on frequency of gout flares: a proof-of-concept randomised controlled trial
2012
Metabolic syndrome meets osteoarthritis
2012
Glioblastoma and Other Malignant Gliomas
2013 Standout
Effects of Tumour Necrosis Factor Antagonists on Insulin Sensitivity/Resistance in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
2015
Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB
2005 Standout
Gouty attacks occur frequently in postoperative gastric bypass patients
2007
Flexible polymer transistors with high pressure sensitivity for application in electronic skin and health monitoring
2013 Standout
The Dietary Approaches to Stop Hypertension (DASH) diet, Western diet, and risk of gout in men: prospective cohort study
2017
Serum uric acid in US adolescents: distribution and relationship to demographic characteristics and cardiovascular risk factors
2012
Uric Acid and Cardiovascular Risk
2008 Standout
Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents
2017 Standout
Cardiac and Vascular Consequences of Pre‐Hypertension in Youth
2011
Trans Fatty Acids and Cardiovascular Disease
2006 Standout
Immunogenic cell death in cancer and infectious disease
2016 Standout
Insulin resistance in rheumatoid arthritis: the impact of the anti‐TNF‐α therapy
2010
Impact of bariatric surgery on serum urate targets in people with morbid obesity and diabetes: a prospective longitudinal study
2013
Prevalence of the metabolic syndrome in patients with gout: The Third National Health and Nutrition Examination Survey
2007
The Pathogenesis of Rheumatoid Arthritis
2011 Standout
Gout
2009 Standout
Inflammation, stress, and diabetes
2005 Standout
Inflammation and insulin resistance
2006 Standout
Type 2 diabetes as an inflammatory disease
2011 Standout
EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee For International Clinical Studies Including Therapeutics (ESCISIT)
2006 Standout
Atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus
2008
Cellular senescence in ageing: from mechanisms to therapeutic opportunities
2020 Standout
Epidemiology of gout in women: Fifty‐two–year followup of a prospective cohort
2010
Purine-rich foods intake and recurrent gout attacks
2012
Adipokines in inflammation and metabolic disease
2011 Standout
Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study
2017
Comorbidities of Gout and Hyperuricemia in the US General Population: NHANES 2007-2008
2012
Arterial blood pressure measurement and pulse wave analysis-–their role in enhancing cardiovascular assessment
2009
Association between Water Intake, Chronic Kidney Disease, and Cardiovascular Disease: A Cross-Sectional Analysis of NHANES Data
2013 Standout
Effects of infliximab treatment on insulin resistance in patients with rheumatoid arthritis and ankylosing spondylitis
2004
Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE
2011
Resistin: functional roles and therapeutic considerations for cardiovascular disease
2011
Purine-Rich Foods, Dairy and Protein Intake, and the Risk of Gout in Men
2004
Glucocorticoid-Induced Hyperglycemia
2013
The serum urate-lowering impact of weight loss among men with a high cardiovascular risk profile: the Multiple Risk Factor Intervention Trial
2010
Gout
2016 Standout
Evaluation of the association between the first observation and the longitudinal change in C-reactive protein, and all-cause mortality
2007
Gout in Solid Organ Transplantation
2005
Prevalence of type 2 diabetes and impaired fasting glucose in patients affected by rheumatoid arthritis
2017
The epidemiology of Parkinson's disease: risk factors and prevention
2016 Standout
Effect of conjugated linoleic acid, vitamin E and their combination on lipid profiles and blood pressure of Iranian adults with active rheumatoid arthritis
2008
Therapeutic Effects of Xanthine Oxidase Inhibitors: Renaissance Half a Century after the Discovery of Allopurinol
2006 Standout
Gout
2003
Poor clinical response in rheumatoid arthritis is the main risk factor for diabetes development in the short-term: A 1-year, single-centre, longitudinal study
2017
Atherosclerosis
2019 Standout
Energy regulation and neuroendocrine–immune control in chronic inflammatory diseases
2010
A comparison of regression trees, logistic regression, generalized additive models, and multivariate adaptive regression splines for predicting AMI mortality
2006
British Society for Rheumatology and British Health Professionals in Rheumatology Guideline for the Management of Gout
2007
Gout and the risk of type 2 diabetes among men with a high cardiovascular risk profile
2008
Febuxostat Compared with Allopurinol in Patients with Hyperuricemia and Gout
2005 Standout
Improvement in the management of gout is vital and overdue: an audit from a UK primary care medical practice
2013
Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a cross-sectional study, the CARRÉ Investigation
2008
Serum Levels of Calreticulin in Correlation with Disease Activity in Patients with Rheumatoid Arthritis
2013
ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)
2011 Standout
The role of resistin as a regulator of inflammation: Implications for various human pathologies
2009
Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity‐score matched samples
2009 Standout
Inflammation, metaflammation and immunometabolic disorders
2017 StandoutNature
Exploring the full spectrum of macrophage activation
2008 Standout
Diabetes mellitus risk in rheumatoid arthritis: Reduced incidence with anti–tumor necrosis factor α therapy
2011
Effects of bariatric surgery on gout incidence in the Swedish Obese Subjects study: a non-randomised, prospective, controlled intervention trial
2016
Metabolic syndrome in rheumatic diseases: epidemiology, pathophysiology, and clinical implications
2008
Inflammation in obesity, diabetes, and related disorders
2022 Standout
Adipose Tissue as an Endocrine Organ
2004 Standout
Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients?
2007
Management of Acute and Chronic Gouty Arthritis
2004
Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America
2019 Standout
Lipoprotein Alterations, Hepatic Lipase Activity, and Insulin Sensitivity in Subclinical Hypothyroidism: Response to L-T 4 Treatment
2007
Serum Concentrations of Uric Acid and the Metabolic Syndrome Among US Children and Adolescents
2007
Lipid profiles among US elderly with untreated rheumatoid arthritis--the Third National Health and Nutrition Examination Survey.
2005
Adipokines in Arthritis: New Kids on the Block
2009
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases
2012 Standout
Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.
2006
Guidelines for the Primary Prevention of Stroke
2014 Standout
Lab-on-Skin: A Review of Flexible and Stretchable Electronics for Wearable Health Monitoring
2017 Standout
Comprehensive dietary education in treated gout patients does not further improve serum urate
2014
Knee osteoarthritis has doubled in prevalence since the mid-20th century
2017 Standout
Thyroid Hormone Regulation of Metabolism
2014 Standout
Effects of the Dietary Approaches to Stop Hypertension (DASH) Diet and Sodium Intake on Serum Uric Acid
2016
Pathogenesis of Gout
2005
Anti-tumor necrosis factor-alpha blockade improves insulin resistance in patients with rheumatoid arthritis.
2006
Gout
2021 Standout
Inflammatory Mechanisms in Obesity
2011 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Inflammation and Activated Innate Immunity in the Pathogenesis of Type 2 Diabetes
2004
Joint British Societies’ consensus recommendations for the prevention of cardiovascular disease (JBS3)
2014
IL-1 inhibition improves insulin resistance and adipokines in rheumatoid arthritis patients with comorbid type 2 diabetes
2019
Diabetic Neuropathy: A Position Statement by the American Diabetes Association
2016 Standout
Hypoxia-Inducible Factor 1α Is a Critical Downstream Mediator for Hypoxia-Induced Mitogenic Factor (FIZZ1/RELMα)–Induced Pulmonary Hypertension
2015 StandoutNobel
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Association between chronic immune-mediated inflammatory diseases and cardiovascular risk
2017
Osteoarthritis: an update with relevance for clinical practice
2011 Standout
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Works of Patrick H Dessein being referenced
Metabolic syndrome and subclinical atherosclerosis in rheumatoid arthritis.
2006
Cardiovascular risk in rheumatoid arthritis versus osteoarthritis: acute phase response related decreased insulin sensitivity and high-density lipoprotein cholesterol as well as clustering of metabolic syndrome features in rheumatoid arthritis
2002
Effects of disease modifying agents and dietary intervention on insulin resistance and dyslipidemia in inflammatory arthritis: a pilot study
2002
Autonomic dysfunction in systemic sclerosis: Sympathetic overactivity and instability
1992
Prevention of cardiovascular disease in rheumatoid arthritis
2015
Biomarkers of endothelial dysfunction, cardiovascular risk factors and atherosclerosis in rheumatoid arthritis
2005
Is prehypertension an independent predictor of target organ changes in young-to-middle-aged persons of African descent?
2008
Insulin resistance and impaired beta cell function in rheumatoid arthritis
2006
Beneficial effects of weight loss associated with moderate calorie/carbohydrate restriction, and increased proportional intake of protein and unsaturated fat on serum urate and lipoprotein levels in gout: a pilot study
2000
Subclinical Hypothyroidism is Associated with Insulin Resistance in Rheumatoid Arthritis
2004
Influence of nonclassical cardiovascular risk factors on the accuracy of predicting subclinical atherosclerosis in rheumatoid arthritis.
2007
Anti-TNF-alpha therapy modulates resistin in patients with rheumatoid arthritis.
2008
High sensitivity C-reactive protein as a disease activity marker in rheumatoid arthritis.
2004
High-grade inflammation, circulating adiponectin concentrations and cardiovascular risk factors in severe rheumatoid arthritis.
2009
Traditional and nontraditional cardiovascular risk factors are associated with atherosclerosis in rheumatoid arthritis.
2005
Independent role of conventional cardiovascular risk factors as predictors of C-reactive protein concentrations in rheumatoid arthritis.
2007
Glucocorticoids and insulin sensitivity in rheumatoid arthritis.
2004
The acute phase response does not fully predict the presence of insulin resistance and dyslipidemia in inflammatory arthritis.
2002